ATE273979T1 - Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis - Google Patents

Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis

Info

Publication number
ATE273979T1
ATE273979T1 AT01907784T AT01907784T ATE273979T1 AT E273979 T1 ATE273979 T1 AT E273979T1 AT 01907784 T AT01907784 T AT 01907784T AT 01907784 T AT01907784 T AT 01907784T AT E273979 T1 ATE273979 T1 AT E273979T1
Authority
AT
Austria
Prior art keywords
osteoporosis
treatment
xanthine derivatives
intermediate products
derivatives
Prior art date
Application number
AT01907784T
Other languages
English (en)
Inventor
Guenter Johannes Billen
Yamina Bouali
Francois Nique
Yusuke Satoh
Jean-Paul Vevert
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE273979T1 publication Critical patent/ATE273979T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01907784T 2000-02-15 2001-02-14 Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis ATE273979T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001845A FR2804958B1 (fr) 2000-02-15 2000-02-15 Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
PCT/FR2001/000420 WO2001060824A1 (fr) 2000-02-15 2001-02-14 Derives de xanthine, intermediaires et application au traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
ATE273979T1 true ATE273979T1 (de) 2004-09-15

Family

ID=8847004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907784T ATE273979T1 (de) 2000-02-15 2001-02-14 Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis

Country Status (9)

Country Link
EP (1) EP1257552B1 (de)
AT (1) ATE273979T1 (de)
AU (1) AU2001235668A1 (de)
DE (1) DE60104986T2 (de)
DK (1) DK1257552T3 (de)
ES (1) ES2227134T3 (de)
FR (1) FR2804958B1 (de)
PT (1) PT1257552E (de)
WO (1) WO2001060824A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009091A1 (en) 2002-06-17 2004-01-29 Glaxo Group Limited Purine derivatives as liver x receptor agonists
CA2711558C (en) 2008-01-04 2016-12-13 Intellikine, Inc. Phosphatidyl inositol-3 kinase inhibiting compounds
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
AU2012205669B2 (en) 2011-01-10 2015-08-20 Infinity Pharmaceuticals Inc. Processes for preparing isoquinolinones and solid forms of isoquinolinones
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
KR102229478B1 (ko) 2012-11-01 2021-03-18 인피니티 파마슈티칼스, 인코포레이티드 Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
WO2015003881A1 (en) * 2013-07-08 2015-01-15 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
US20150320755A1 (en) 2014-04-16 2015-11-12 Infinity Pharmaceuticals, Inc. Combination therapies
MX391135B (es) 2016-06-24 2025-03-21 Infinity Pharmaceuticals Inc Terapias de combinacion.
CN109503583A (zh) * 2018-12-14 2019-03-22 南京纽邦生物科技有限公司 1,7-二甲基黄嘌呤及其中间体的制备方法、中间体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006976A1 (en) * 1990-10-18 1992-04-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivative
CA2218548A1 (en) * 1995-05-19 1996-11-21 Chiroscience Limited Xanthines and their therapeutic use
JPH09169665A (ja) * 1995-12-21 1997-06-30 Kenichi Miyamoto 骨粗鬆症治療剤
ATE226583T1 (de) * 1996-06-07 2002-11-15 Hoechst Ag Verwendung von theophyllinderivaten zur behandlung und propylaxe von schockzuständen, neue xanthinverbindungen und verfahren zu deren herstellung
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
JPH1192379A (ja) * 1997-07-24 1999-04-06 Kunio Takaoka 骨疾患の予防または治療剤

Also Published As

Publication number Publication date
FR2804958A1 (fr) 2001-08-17
DE60104986T2 (de) 2005-08-25
PT1257552E (pt) 2005-01-31
AU2001235668A1 (en) 2001-08-27
ES2227134T3 (es) 2005-04-01
WO2001060824A1 (fr) 2001-08-23
EP1257552A1 (de) 2002-11-20
DE60104986D1 (de) 2004-09-23
FR2804958B1 (fr) 2005-07-08
EP1257552B1 (de) 2004-08-18
DK1257552T3 (da) 2004-12-20

Similar Documents

Publication Publication Date Title
FI913478A0 (fi) Diazinderivat.
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
DK1274692T3 (da) Quinazolinforbindelser
BG101582A (bg) Пиперазинови производни, съдържащите ги лекарствени форми, приложението им и метод за тяхното получаване
AR024390A1 (es) Nuevos compuestos
ATE202702T1 (de) Verwendung von oestrogenagonisten und - antagonisten zur herstellung eines medikaments zur behandlung von atherosklerose, unabhängig von lipidsenkung
DE69607650D1 (de) 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung
YU30902A (sh) Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE308533T1 (de) Zwischenprodukt und verfahren zur teilsynthese von paclitaxel und dessen analogen
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
ZA939118B (en) Processes for preparing 2-cyano-3-hydroxy-propenamides and pharmaceutical compositions containing them
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE59606725D1 (de) Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE69002340D1 (de) Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung.
ATE186214T1 (de) Verwendung von rosmanolderivaten zur herstellung von antiradikalischen und/oder antilipoperoxidativen und/oder hepatotropen arzneistoffen
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
ATE56437T1 (de) Verfahren zur herstellung von 1,4dihydropyridinderivaten ueber neue zwischenprodukte.
ATE294155T1 (de) Eine methode zur herstellung von verbindungen der formel 1 und derivaten
AR022044A1 (es) Derivados de 1,5-benzodiazepina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1257552

Country of ref document: EP